Drugs in R&D

Systems Biology: An Evolving Approach in Drug Discovery and Development
pp. 203-216(14)
Authors: Ho, R.L.; Lieu, C.A.

Fragment-Based Approach to Drug Lead Discovery: Overview and Advances in Various Techniques
pp. 217-227(11)
Authors: Fattori, Daniela; Squarcia, Antonella; Bartoli, Sandra

Adaptive Clinical Trials: Progress and Challenges
pp. 229-242(14)
Authors: Coffey, Christopher S.; Kairalla, John A.

Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus: A Randomized, Parallel-Group, Placebo-Controlled, 8-Week Study
pp. 243-250(8)
Authors: Usharani, P.; Mateen, A.A.; Naidu, M.U.R.; Raju, Y.S.N.; Chandra, Naval

Aminaftone, a Derivative of 4-Aminobenzoic Acid, Downregulates Endothelin-1 Production in ECV304 Cells: An In Vitro Study
pp. 251-257(7)
Authors: Scorza, Raffaella; Santaniello, Alessandro; Salazar, Giulia; Lenna, Stefania; Colombo, Gualtiero; Turcatti, Flavia; Beretta, Lorenzo

Aflibercept: AVE 0005, AVE 005, AVE0005, VEGF Trap - Regeneron, VEGF Trap (R1R2), VEGF Trap-Eye
pp. 261-269(9)
Author: Adis International Limited,

Beclometasone Oral - DOR BioPharma: Beclomethasone Oral - DOR BioPharma
pp. 271-276(6)
Author: Adis International Limited,